Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro

<i>Background and Objectives:</i> Myricetin, a flavonoid compound, was demonstrated to effectively arrest the cell-to-cell fusion and syncytial development triggered by Nipah virus (NiV) fusion (F) and attachment (G) envelope glycoproteins in vitro involving two permissive mammalian cell...

Full description

Saved in:
Bibliographic Details
Main Authors: Ananda Murali Rayapati, Chanda Chandrasekhar, Sudarsana Poojari, Bhadra Murthy Vemulapati
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/17/6/827
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849433711200698368
author Ananda Murali Rayapati
Chanda Chandrasekhar
Sudarsana Poojari
Bhadra Murthy Vemulapati
author_facet Ananda Murali Rayapati
Chanda Chandrasekhar
Sudarsana Poojari
Bhadra Murthy Vemulapati
author_sort Ananda Murali Rayapati
collection DOAJ
description <i>Background and Objectives:</i> Myricetin, a flavonoid compound, was demonstrated to effectively arrest the cell-to-cell fusion and syncytial development triggered by Nipah virus (NiV) fusion (F) and attachment (G) envelope glycoproteins in vitro involving two permissive mammalian cell lines. <i>Methods:</i> Time-of-addition assays were carried out using codon-optimized NiV wild type (WT) F and G plasmids followed by a challenge with the addition of myricetin 1 h and 6 h post-transfection in HEK 293T and Vero cells. <i>Results:</i> Upon evaluating different myricetin concentrations, it was determined that a 100 μM concentration of myricetin effectively inhibited 64–80% of syncytia in HEK and Vero cells. <i>Interpretation & Conclusions:</i> In this study, we concluded that myricetin mitigated the syncytial development in HEK and Vero cell lines. Given the flavonoid attributes of myricetin which is widely present in fruits, vegetables, tea, and wine, it may be regarded as a phytonutrient and a safer antiviral alternative against Nipah virus infections. Due to the BSL-4 nature of the virus, further research involving live virus culture is necessary to confirm myricetin as a potential antiviral compound for the mitigation of pathological effects of NiV infections.
format Article
id doaj-art-ae9a41f13b274acdb911dc137b3ac4e3
institution Kabale University
issn 1999-4915
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-ae9a41f13b274acdb911dc137b3ac4e32025-08-20T03:26:56ZengMDPI AGViruses1999-49152025-06-0117682710.3390/v17060827Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In VitroAnanda Murali Rayapati0Chanda Chandrasekhar1Sudarsana Poojari2Bhadra Murthy Vemulapati3Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur 522502, IndiaKoneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur 522502, IndiaCool Climate Oenology and Viticulture Institute, Brock University, St. Catharines, ON L2S 3A1, CanadaKoneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur 522502, India<i>Background and Objectives:</i> Myricetin, a flavonoid compound, was demonstrated to effectively arrest the cell-to-cell fusion and syncytial development triggered by Nipah virus (NiV) fusion (F) and attachment (G) envelope glycoproteins in vitro involving two permissive mammalian cell lines. <i>Methods:</i> Time-of-addition assays were carried out using codon-optimized NiV wild type (WT) F and G plasmids followed by a challenge with the addition of myricetin 1 h and 6 h post-transfection in HEK 293T and Vero cells. <i>Results:</i> Upon evaluating different myricetin concentrations, it was determined that a 100 μM concentration of myricetin effectively inhibited 64–80% of syncytia in HEK and Vero cells. <i>Interpretation & Conclusions:</i> In this study, we concluded that myricetin mitigated the syncytial development in HEK and Vero cell lines. Given the flavonoid attributes of myricetin which is widely present in fruits, vegetables, tea, and wine, it may be regarded as a phytonutrient and a safer antiviral alternative against Nipah virus infections. Due to the BSL-4 nature of the virus, further research involving live virus culture is necessary to confirm myricetin as a potential antiviral compound for the mitigation of pathological effects of NiV infections.https://www.mdpi.com/1999-4915/17/6/827antiviralsmyricetinNipah virusF and G envelope glycoproteinssyncytiain vitro assay
spellingShingle Ananda Murali Rayapati
Chanda Chandrasekhar
Sudarsana Poojari
Bhadra Murthy Vemulapati
Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro
Viruses
antivirals
myricetin
Nipah virus
F and G envelope glycoproteins
syncytia
in vitro assay
title Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro
title_full Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro
title_fullStr Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro
title_full_unstemmed Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro
title_short Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro
title_sort myricetin restricts the syncytial development triggered by nipah virus envelope glycoproteins in vitro
topic antivirals
myricetin
Nipah virus
F and G envelope glycoproteins
syncytia
in vitro assay
url https://www.mdpi.com/1999-4915/17/6/827
work_keys_str_mv AT anandamuralirayapati myricetinrestrictsthesyncytialdevelopmenttriggeredbynipahvirusenvelopeglycoproteinsinvitro
AT chandachandrasekhar myricetinrestrictsthesyncytialdevelopmenttriggeredbynipahvirusenvelopeglycoproteinsinvitro
AT sudarsanapoojari myricetinrestrictsthesyncytialdevelopmenttriggeredbynipahvirusenvelopeglycoproteinsinvitro
AT bhadramurthyvemulapati myricetinrestrictsthesyncytialdevelopmenttriggeredbynipahvirusenvelopeglycoproteinsinvitro